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Chris Plinston, Dorothy Kisielewski,  
Jesús de Pedro-Cuesta, Alberto Rábano,  
Robert G. Will,1 Jean C. Manson1
We investigated transmission characteristics of variant 
Creutzfeldt-Jakob disease in a mother and son from Spain. 
Despite differences in patient age and disease manifesta-
tions, we found the same strain properties in these patients 
as in UK vCJD cases. A single strain of agent appears to be 
responsible for all vCJD cases to date.
In 2008 in Spain, 2 cases of variant Creutzfeldt-Jakob dis-ease (vCJD) in first-degree relatives were identified. After 
the death of a 41-year-old man (patient 1) from vCJD, his 
64-year-old mother (patient 2) began showing symptoms of 
anxiety and depression and, 2 months later, a gait disorder 
and progressive dementia. Although the clinical duration 
was relatively short and the early symptoms uncommon in 
comparison to vCJD cases in the United Kingdom, the over-
all clinical phenotype and posterior thalamic hyperintensities 
as seen in an MRI brain scan led to a diagnosis of suspected 
vCJD. Neuropathological examination confirmed the diag-
nosis of vCJD. Both patients were 129MM homozygous, 
had never received a blood transfusion or tissue graft, and 
had lived in the same town within the Castilla-León region 
of Spain (Table 1) (1). The region is a farming area at high 
risk for bovine spongiform encephalopathy (BSE); 3 of the 
5 cases of vCJD reported in Spain came from this region (1). 
The patients had similar eating habits, which included in-
gestion of bovine brain. We conducted a study to determine 
whether these 2 vCJD cases were caused by the BSE agent, 
whether the agent strain was similar to previously character-
ized human vCJD cases, and whether the age of the patients 
would influence the strain characteristics.
The Study
We challenged cohorts of mice (RIII, C57BL/6J, and 
VM) with frozen central nervous system tissue from the 
2 patients from Spain and 1 patient originating from the 
United Kingdom (Table 1) (2). The Lothian NHS Board 
Research Ethics Committee provided ethical consent for 
the use of the UK material for research; the vCJD tissue 
samples from Spain were provided by NEIKER-Tecnalia 
(Derio, Spain). We conducted inoculation, clinical scor-
ing, and neuropathological and biochemical analysis of the 
mice as previously described (3–5). Animal studies were 
conducted according to the regulations of the UK Home 
Office Animals (Scientific Procedures) Act 1986.
All 3 vCJD brain isolates transmitted successfully, 
with the appearance of clinical and pathological signs as-
sociated with spongiform encephalopathy transmission 
(Table 2). Inocula from patients 1 and 2 showed the same 
temporal order of clinical endpoint in each mouse line 
when compared with inocula from the UK case (Figure 1). 
We observed a wide range of incubation periods for each 
mouse line both within and between inocula (Table 2), 
which is not unusual in primary transmissions.
We generated vacuolation profiles for each mouse 
line/inocula combination. In RIII and C57BL/6J mice, we 
observed moderate to mild vacuolation in the medulla and 
hypothalamus; C57BL/6J mice also exhibited mild vacu-
olation in the cerebellar peduncle (Figure 2, panels A, B). 
VM mice showed mild to moderate vacuolation in the me-
dulla, thalamus, and septum, but typically not in the hy-
pothalamus (Figure 2, panel C). Although the distribution 
of vacuolation was similar between isolates in the different 
mouse lines, the intensity of vacuolation distribution var-
ied. This difference was most evident in the VM mice, in 
which the transmission from patient 2 appeared to have a 
lower intensity of vacuolation than that of patient 1 and the 
UK patient.
We observed a widespread accumulation of abnormal 
prion protein (PrP) throughout the brains of inoculated 
mice, with greatest accumulations apparent in the medul-
la, hypothalamus, and thalamic areas. We observed vari-
ability in the intensity of PrP accumulation between mice 
both within and between groups. Fine punctate/punctate 
deposits were the most common form of PrP accumula-
tion in the mice; however, subtle differences were apparent 
in the hippocampus. In RIII and C57BL/6J, we observed 
a characteristic PrP deposition in the CA2 region of the 
hippocampus, whereas VM exhibited PrP deposition in 
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the molecular dentate gyrus with occasional small plaques 
present in the corpus callosum (online Technical Appen-
dix Figure 1, https://wwwnc.cdc.gov/EID/article/23/9/17-
0159-Techapp1.pdf).
Biochemical analysis of inocula confirmed the pres-
ence of protease-resistant prion protein (PrPres) in each of 
the 3 isolates. We identified a similar PrPres type in iso-
lates from the Spain patients that resembled that of the UK 
patient and the vCJD diagnostic standard, with a banding 
pattern dominated by the diglycosylated fragment of the 
protein and an unglycosylated fragment of ≈19 kDa (on-
line Technical Appendix Figure 2). PrPres was readily de-
tected in the brain of RIII and VM mice challenged with all 
3 isolates. We identified a similar glycosylation pattern in 
both mouse lines; a dominant diglycosylated fragment of 
≈30 kDa and an unglycosylated fragment of ≈20k Da. We 
found no apparent differences between the different mouse 
line/inocula combinations (online Technical Appendix 
Figure 3).
Conclusions
This transmission study of central nervous system tissue 
from 2 first-degree relatives with vCJD confirms that the 
same infectious transmissible spongiform encephalopathy 
(TSE) agent was responsible for both cases. Comparisons 
of incubation period, TSE neuropathology, and PrPres bio-
chemistry indicate that this strain is consistent with that 
of a UK case of vCJD and with historical vCJD transmis-
sion data (6). The epidemiologic investigation of the 2 
related patients indicated that they had shared a common 
residence and dietary habits, including cattle brain con-
sumption, for >30 years. This finding suggests a common 
source of infection linked to the consumption of high-
risk material in a known BSE area, and these transmis-
sion studies support the hypothesis that consumption of 
BSE-contaminated food products is a major risk factor 
for vCJD (7).
A feature of the UK vCJD epidemic was the relatively 
young age of the patients at onset. During 1995–2014, only 
6 of 177 cases of vCJD identified in the United Kingdom 
were in persons >55 years of age at the onset of symptoms. 
Clinical phenotypes in these 6 patients were less consistent 
than those observed in younger patients (8). The evidence 
suggests that age is not a barrier to either infection or de-
veloping the disease; diagnosis of vCJD may become more 
important as exposed populations become older. Our study 
demonstrates that older persons harbor the vCJD agent in 
the central nervous system in a similar manner to younger 
 
Table 1. Demographic and clinical features of 2 case-patients from Spain with variant CJD and reference cases from the United 
Kingdom* 
Characteristic Patient 1 Patient 2 UK cases, n = 150 
Patient sex M F  
Case-patient age at illness onset, y 41 64 29 (mean) 
Case-patient age at death, y 41 64 30 (mean) 
Disease duration, mo 9 7 14 (mean) 
Early visual symptoms + – 6% 
Early unsteadiness – + 11% 
No typical appearance of sporadic CJD on EEG + + 100% 
Bilateral symmetric pulvinar high signal on MRI scan of brain Yes Yes 93% 
Positive tonsil biopsy result ND ND 19% 
History of travel to or residence in United Kingdom No No 100% 
Codon 129MM Yes Yes 100%† 
Type 2B PrP Yes Yes 100%† 
*CJD, Creutzfeldt-Jakob disease; EEG, electroencephalogram; MRI, magnetic resonance imaging; PrP, prion protein; ND, not done; –, negative;  
+, positive. 
†Of those tested.  
 
 
Table 2. Results of inoculation of brain tissue homogenates from 2 patients from Spain with vCJD and a reference patient from the 
United Kingdom into a panel of wild-type mice* 
Brain inoculum source and mouse line 
No. mice positive/no. total 
Incubation period, d, ± SEM (range) Clinical signs of prion disease Vacuolar pathology 
UK reference case    
 RIII 10/15 10/15 395.3 ± 17.9 (295–489) 
 C57BL/6 13/17 15/17 523.7 ± 19.7 (372–637) 
 VM 13/16 14/16 472.2 ± 16.1 387–552 
Patient 1    
 RIII 14/17 15/17 417 ± 14.2 (336–516) 
 C57BL/6 12/18 12/18 588.4 ± 25.1 (405–706) 
 VM 7/18 11/18 472.2 ± 16.1 (387–552) 
Patient 2    
 RIII 12/16 13/16 427.5 ± 18.4 (323–547) 
 C57BL/6 9/18 11/18 604.9 ± 12.4 (567–692) 
 VM 4/16 7/16 524 ± 16.8 (501–573) 
*Bold indicates significant difference (p<0.05) when compared to the mouse line challenged with UK vCJD. vCJD, variant Creutzfeldt-Jakob disease. 
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persons. Small differences in incubation periods and the 
intensity of TSE vacuolation are apparent, which may be 
indicative of variation in the titer of the isolates. It is un-
known when the 2 patients from Spain were infected, but 
if they were exposed at the same time, the 23-year differ-
ence in age at time of exposure may have influenced patho-
genesis and the ability of the agent to replicate. A delay 
in neuroinvasion or slower rates of replication in the brain 
could explain why clinical symptoms are more variable in 
older patients. 
Although our study demonstrates that clinical pre-
sentation and infective titer may differ between patients, 
the overall strain characteristics remain similar. Thus, the 
vCJD strain can be identified using our strain typing panel 
regardless of these variable factors.
This study highlights the need for awareness of vCJD in 
older age groups, particularly in patients with clinical mani-
festations of atypical dementias. These findings add addition-
al supporting evidence to the hypothesis that a single strain 
of TSE agent is responsible for vCJD cases, regardless of 
geographic origin or age at infection, and indirectly support 
the hypothesis of a dietary origin for primary cases of vCJD.
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